Format

Send to

Choose Destination
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):180-90. doi: 10.1016/j.mce.2010.12.015. Epub 2010 Dec 15.

Cellular immunity and immunopathology in autoimmune Addison's disease.

Author information

1
Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway. eirik.bratland@med.uib.no

Abstract

Autoimmune adrenocortical failure, or Addison's disease, is a prototypical organ-specific autoimmune disorder. In common with related autoimmune endocrinopathies, Addison's disease is only manageable to a certain extent with replacement therapy being the only treatment option. Unfortunately, the available therapy does not restore the physiological hormone levels and biorhythm. The key to progress in treating and preventing autoimmune Addison's disease lies in improving our understanding of the predisposing factors, the mechanisms responsible for the progression of the disease, and the interactions between adrenal antigens and effector cells and molecules of the immune system. The aim of the present review is to summarize the current knowledge on the role of T cells and cellular immunity in the pathogenesis of autoimmune Addison's disease.

PMID:
21167251
DOI:
10.1016/j.mce.2010.12.015
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center